Ltd. (FORTY) Company Overview

What does Formula Systems do?

Formula Systems (1985) Ltd. is an Israeli information-technology holding company rather than a single-product software vendor. Its ordinary shares trade on the Tel Aviv Stock Exchange and its American Depositary Shares, each representing one ordinary share, trade on the Nasdaq Global Select Market. The company's official company profile describes a group that builds, implements and supports software, IT services and business systems across commercial, government, defense, healthcare, finance and other regulated markets.

Why is the holding-company structure important?

Formula allocates capital, appoints leadership and supports acquisitions, while its operating companies retain their own brands, customers, specialist workforces and, in several cases, separate public listings. The main current platforms are Matrix IT, Michpal Technologies and TSG IT Advanced Systems, supplemented by staffing, digital commerce, infrastructure and other businesses. Formula also retained an 18.68% economic interest in the former Sapiens business through SI Swan UK Topco after Advent completed its acquisition of Sapiens in December 2025.

This architecture makes Formula economically different from a conventional software company. Consolidated revenue reflects controlled subsidiaries, equity-accounted affiliates contribute through separate profit lines, and substantial non-controlling interests mean that group profit is not identical to profit attributable to Formula shareholders. The 2025 Form 20-F is therefore best read as a portfolio document: the key questions are what Formula owns, how each asset grows, and how cash moves from subsidiaries to the parent.

How does Formula Systems make money, and which businesses matter most?

What are the core revenue engines?

Matrix is the dominant operating platform. Following its merger with Magic Software, Matrix reported Q1 2026 revenue of approximately $681.6 million and operating income of about $65.1 million. Michpal reported Q1 2026 revenue of $16.9 million and adjusted EBITDA of $6.5 million. TSG, which is smaller but faster-growing, reported Q1 2026 revenue of $38.7 million and operating income of NIS 13.1 million. These figures are not a simple consolidated revenue bridge because ownership and accounting treatment differ, but they reveal where operating scale and growth reside.

Which strategic turning points created today's portfolio?

Formula's history is best understood through capital-allocation decisions rather than product launches. The company repeatedly acquired meaningful stakes, allowed portfolio companies to remain operationally distinct, and monetized or recombined assets when scale or valuation justified it.

1. 1985
   Formula was incorporated in Israel, establishing the legal platform that later became a federation of technology companies.
2. 2008
   Guy Bernstein became chief executive officer, beginning a long period of portfolio continuity and acquisition-led development.
3. 2010
   Asseco Poland became the controlling shareholder, connecting Formula to a larger European software federation while preserving its listed structure.
4. 2016–2017
   Formula acquired 50% of TSG for $25.8 million and then acquired Michpal for $22.1 million, adding defense technology and recurring payroll software.
5. 2024–2025
   TSG completed its TASE listing, while Michpal completed a September 2025 IPO that raised approximately $87.3 million net of issuance expenses.
6. December 2025
   Advent completed the Sapiens acquisition. Formula lost control, retained an 18.68% indirect interest and recognized a large disposal-related gain.
7. February 2026
   Matrix and Magic completed an all-stock merger; former Magic holders received 31.125% of the combined Matrix on a fully diluted basis.

Why do the Sapiens sale and Matrix–Magic merger matter?

The Sapiens transaction converted a long-held controlled asset into cash and a minority financial interest. It generated the exceptional FY2025 attributable profit, lifted parent liquidity and enabled a $200 million special dividend. The Matrix–Magic merger moved in the opposite direction: it concentrated two controlled technology platforms into one larger listed company. Formula's 2025 results release said the combined company had pro forma FY2025 revenue of roughly $2.4 billion, EBITDA of about $0.3 billion and net income attributable to shareholders of about $129 million.

What does Formula Systems' latest quarter show?

The Q1 2026 earnings release shows strong underlying growth but also an important one-time item. Revenue rose from $619.4 million in Q1 2025 to $738.3 million in Q1 2026. Gross profit increased to $146.0 million from $120.2 million, keeping gross margin near 19.8%. Reported operating income rose 65.6% to $82.0 million, but included a $16.8 million gain connected with TSG's private placement and employee equity exercises. Excluding that gain, operating income was $65.2 million, still 31.7% above the prior-year quarter.

How much of the profit belongs to Formula shareholders?

Is revenue momentum broad or dependent on one quarter?

How strong are the balance sheet and capital-allocation capacity?

Formula entered 2026 with unusually high liquidity after the Sapiens transaction. At March 31, 2026, consolidated cash, cash equivalents and short-term deposits were approximately $1.18 billion. Parent-only cash was $740.9 million, while parent investments in subsidiaries and a jointly controlled entity totaled $606.2 million and the retained Sapiens-related financial asset was carried at $300.0 million. This distinction matters because consolidated cash includes subsidiary cash that may not be freely deployable by the parent.

What did Formula return to shareholders?

The special-dividend filing demonstrates management's willingness to distribute transaction proceeds rather than retain all cash indefinitely. It also means that post-dividend liquidity should be assessed separately from the March 31 balance sheet. A DCF model should not treat the Sapiens disposal gain as recurring operating profit, but it should recognize the cash realized, the retained minority asset and the reduction in future consolidated Sapiens earnings.

What gives Formula Systems a competitive advantage?

A federation model with specialized operating companies

Formula's advantage is not one patent or one network effect. It is an organizational capability: owning specialist companies with local management, public-market access and domain expertise while providing capital-allocation oversight. Matrix supplies scale and broad enterprise delivery; Michpal supplies sticky payroll and compliance workflows; TSG supplies mission-critical defense and public-sector technology. The group's official group structure illustrates how these businesses remain distinct rather than being forced into one centralized brand.

Where do switching costs come from?

Large IT projects are embedded in customer workflows, data, security architecture and regulatory processes. Replacing a systems integrator or payroll platform can require migration, testing, retraining and operational risk. TSG's defense and homeland-security work adds certification, long procurement cycles and mission-critical reliability. These factors do not eliminate competition, but they create relationship depth and repeat work that a simple product-price comparison misses.

Formula also benefits from listed subsidiaries. Public listings can provide acquisition currency, transparent valuations and independent capital raising. Michpal's 2025 IPO and TSG's institutional placements illustrate that Formula can fund growth without relying only on parent cash. The trade-off is dilution: TSG's January 2026 financing and employee equity reduced Formula's ownership from 37.33% to 33.08%.

Who competes with Formula Systems, and how is it positioned?

Formula competes at the operating-company level, not under one universal product category. Matrix faces Israeli systems integrators and global consultancies; Michpal faces payroll, HR and financial-software providers; TSG faces defense electronics, intelligence and security integrators. Formula filings have historically identified Israeli rivals such as Hilan, Malam-Team and One, alongside global providers including IBM and Accenture in services and Microsoft, Oracle, HP and Dell in technology and infrastructure categories. Several are also suppliers or partners, which is common in enterprise IT.

Why does Matrix scale matter after the Magic merger?

The merged Matrix reported approximately 17,000 professionals serving organizations in more than 50 countries on its official investor-relations page. Scale improves the ability to staff large programs, cross-sell cloud, cyber, data and software capabilities, and compete for multinational customers. However, services scale is valuable only if utilization, wage discipline and project margins remain controlled. Q1 2026 Matrix operating margin improved to 9.5% from 8.8%, an early positive signal after the merger.

Who owns Formula Systems, and what does governance imply?

Formula has one ordinary-share class with identical voting rights, but ownership is concentrated. The 2026 proxy statement reported 15,334,667 shares outstanding as of June 1, 2026 and disclosed several holders above 5%. Asseco Poland is treated as the controlling shareholder under Israeli law despite owning 25.8%, while chief executive Guy Bernstein owns 11.7%. Together, those positions create a more concentrated governance profile than a widely held U.S. software company.

How is the board structured?

The board consisted of seven directors in the 2026 proxy, including two external directors elected for three-year terms under Israeli Companies Law. Five non-external nominees were presented for annual re-election, and several have direct ties to Asseco. This can support strategic continuity and coordination with the broader Asseco federation, but minority shareholders should monitor related-party approvals, executive compensation and capital-allocation decisions.

What risks and opportunities could change the story?

Which risk is most important for financial modeling?

The most important modeling risk is earnings quality. FY2025 net income attributable to Formula shareholders was $606.5 million, but $570.0 million of contribution was associated with Sapiens, including the disposal gain. Q1 2026 operating income included another $16.8 million capital gain from TSG dilution. These are economically real value-creation events, but they are not recurring margins. Analysts should separate operating profit from portfolio revaluation, disposal gains and discontinued operations.

The second risk is project and labor execution. Formula's official releases identify lengthy sales cycles, complex projects, changing cost estimates, customer disputes, cybersecurity vulnerabilities, privacy regulation, currency movements and risks tied to Israel. A services-heavy model can grow rapidly while margins remain sensitive to utilization and wage inflation. Goodwill and intangibles of $819.1 million at March 31, 2026 add acquisition-related impairment and amortization sensitivity, as demonstrated by the $18.7 million Q4 2025 amortization increase after Formula revised useful-life estimates for certain customer relationships.

Where are the clearest growth opportunities?

Matrix can use the Magic merger to deepen U.S. exposure and combine enterprise integration with software platforms. Michpal can consolidate fragmented payroll, HR and accounting workflows and use its IPO cash for acquisitions; it acquired Zviran Group in April 2026. TSG is expanding through Mabat 3D, manufacturing integration and counter-UAV capabilities. Formula also retains a minority interest in the former Sapiens business, preserving exposure to insurance software, AI and SaaS without consolidating the operation.

Which KPIs matter most for Formula Systems valuation?

Formula needs a hybrid dashboard. Consolidated revenue and operating margin show operating scale, but ownership percentages, parent cash and investee values explain how much of that scale belongs to Formula shareholders. The correct model combines a normalized DCF for recurring operations with a sum-of-the-parts check for listed and minority assets.

How should a DCF treat Formula?

A single consolidated terminal multiple can overstate value if it ignores minority ownership, or understate value if it ignores separately listed stakes and parent cash. The central valuation sensitivities are normalized operating margin, Matrix post-merger growth, acquisition reinvestment returns, the value of the retained Sapiens interest and the amount of liquidity remaining after distributions.

What is the key takeaway from Formula Systems analysis?

Formula Systems matters because it is a listed capital-allocation vehicle built around Israeli and international technology operating companies. Matrix provides scale; Michpal adds recurring vertical-software economics; TSG adds defense-technology growth; and the Sapiens transaction demonstrated that the parent can monetize a mature holding while retaining minority upside. Q1 2026 confirmed that the remaining portfolio can grow without Sapiens, with revenue up 19.2% and adjusted operating income up 31.7% year over year.

What should researchers monitor next?

• Matrix revenue growth and operating margin after the Magic integration.
• Formula's recurring operating income excluding transaction and dilution gains.
• Parent-only cash after the $200 million special dividend and new acquisitions.
• Michpal's revenue, adjusted EBITDA and acquisition returns following its IPO.
• TSG order growth, defense exposure and Formula's ownership after additional financing.
• Trade-receivable growth and working-capital conversion in the services businesses.
• Goodwill, intangible amortization and any impairment indicators.
• Board, controlling-shareholder and related-party decisions disclosed in future filings.

For students and analysts, Formula is a useful case study in holding-company accounting, non-controlling interests, public-subsidiary governance and transaction-adjusted valuation. The most reliable conclusion comes from reading operating performance and portfolio value together rather than choosing one lens.